129 related articles for article (PubMed ID: 15516267)
1. Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteria.
Porzio S; Bossù P; Ruggiero P; Boraschi D; Tagliabue A
BMC Biotechnol; 2004 Oct; 4():27. PubMed ID: 15516267
[TBL] [Abstract][Full Text] [Related]
2. In vivo mucosal delivery of bioactive human interleukin 1 receptor antagonist produced by Streptococcus gordonii.
Ricci S; Macchia G; Ruggiero P; Maggi T; Bossù P; Xu L; Medaglini D; Tagliabue A; Hammarström L; Pozzi G; Boraschi D
BMC Biotechnol; 2003 Sep; 3():15. PubMed ID: 13129437
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer.
Gouze JN; Gouze E; Palmer GD; Liew VS; Pascher A; Betz OB; Thornhill TS; Evans CH; Grodzinsky AJ; Ghivizzani SC
Arthritis Res Ther; 2003; 5(5):R301-9. PubMed ID: 12932294
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector.
Roessler BJ; Hartman JW; Vallance DK; Latta JM; Janich SL; Davidson BL
Hum Gene Ther; 1995 Mar; 6(3):307-16. PubMed ID: 7779914
[TBL] [Abstract][Full Text] [Related]
5. The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.
Ulich TR; Yin SM; Guo KZ; del Castillo J; Eisenberg SP; Thompson RC
Am J Pathol; 1991 Mar; 138(3):521-4. PubMed ID: 1825745
[TBL] [Abstract][Full Text] [Related]
6. The effect of recombinant human interleukin 1 receptor antagonist on the induction phase of antigen induced arthritis in the rabbit.
Lewthwaite J; Blake SM; Hardingham TE; Warden PJ; Henderson B
J Rheumatol; 1994 Mar; 21(3):467-72. PubMed ID: 8006890
[TBL] [Abstract][Full Text] [Related]
7. Purification of human recombinant interleukin 1 receptor antagonist proteins upon Bacillus subtilis sporulation.
Maurizi G; Di Cioccio V; Macchia G; Bossù P; Bizzarri C; Visconti U; Boraschi D; Tagliabue A; Ruggiero P
Protein Expr Purif; 1997 Mar; 9(2):219-27. PubMed ID: 9056487
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
Eriksson C; Tehranian R; Iverfeldt K; Winblad B; Schultzberg M
J Neurosci Res; 2000 Apr; 60(2):266-79. PubMed ID: 10740232
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).
Conti P; Panara MR; Fridas S; Barbacane RC; Grilli A; Placido FC; Reale M; Fiore S
Cell Immunol; 1993 Apr; 147(2):446-57. PubMed ID: 8384086
[TBL] [Abstract][Full Text] [Related]
10. Comparative responses of human and rabbit interleukin-1 in vivo: effect of a recombinant interleukin-1 receptor antagonist.
von Uexküll C; Nourshargh S; Williams TJ
Immunology; 1992 Dec; 77(4):483-7. PubMed ID: 1493919
[TBL] [Abstract][Full Text] [Related]
11. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo.
Gabay C; Porter B; Fantuzzi G; Arend WP
J Immunol; 1997 Dec; 159(12):5905-13. PubMed ID: 9550387
[TBL] [Abstract][Full Text] [Related]
12. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist.
Pan RY; Chen SL; Xiao X; Liu DW; Peng HJ; Tsao YP
Arthritis Rheum; 2000 Feb; 43(2):289-97. PubMed ID: 10693868
[TBL] [Abstract][Full Text] [Related]
13. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
[TBL] [Abstract][Full Text] [Related]
14. Involvement of growth-related protein in lipopolysaccharide-induced rabbit arthritis: cooperation between growth-related protein and IL-8, and interrelated regulation among TNFalpha, IL-1, IL-1 receptor antagonist, IL-8, and growth-related protein.
Matsukawa A; Yoshimura T; Fujiwara K; Maeda T; Ohkawara S; Yoshinaga M
Lab Invest; 1999 May; 79(5):591-600. PubMed ID: 10334570
[TBL] [Abstract][Full Text] [Related]
15. Hematologic and immunomodulatory effects of an interleukin-1 receptor antagonist coinfusion during low-dose endotoxemia in healthy humans.
Granowitz EV; Porat R; Mier JW; Orencole SF; Callahan MV; Cannon JG; Lynch EA; Ye K; Poutsiaka DD; Vannier E
Blood; 1993 Nov; 82(10):2985-90. PubMed ID: 8219190
[TBL] [Abstract][Full Text] [Related]
16. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M
Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory activity of IL-1 receptor antagonist depends on the balance between binding capacity for IL-1 receptor type 1 and IL-1 receptor type II.
Ruggiero P; Bossù P; Macchia G; Del Grosso E; Sabbatini V; Bertini R; Colagrande A; Bizzarri C; Maurizi G; Di Cioccio V; D'Andrea G; Di Giulio A; Frigerio F; Grifantini R; Grandi G; Tagliabue A; Boraschi D
J Immunol; 1997 Apr; 158(8):3881-7. PubMed ID: 9103457
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
Ulich TR; Guo K; Yin S; del Castillo J; Yi ES; Thompson RC; Eisenberg SP
Am J Pathol; 1992 Jul; 141(1):61-8. PubMed ID: 1385928
[TBL] [Abstract][Full Text] [Related]
20. IL-1 Fragment Modulates Immune Response Elicited by Recombinant Bacillus subtilis Spores Presenting an Antigen/Adjuvant Chimeric Protein.
Potocki W; Negri A; Peszyńska-Sularz G; Hinc K; Obuchowski M; Iwanicki A
Mol Biotechnol; 2018 Nov; 60(11):810-819. PubMed ID: 30178298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
